RxDoctor Payments Data

Jeffrey Campbell

Psychiatric/Mental Health · West Springfield, MANPI 1467677922

Payments from drug & device makers

$1,161in general payments, 2019–2025

Across 63 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$842
  • Vanda Pharmaceuticals Inc.$179
  • Neurocrine Biosciences, Inc.$108
  • Lundbeck LLC$18
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$15

What the payments were for

  • Food & beverage$98385%
  • Education$17915%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,161 in reported general payments places this provider in the 75th percentile of 1,284 psychiatric/mental health providers in Massachusetts.

See all psychiatric/mental health providers in Massachusetts

Medicare billing

Part B allowed, 2024
$100,703
Medicare patients
253
Services billed
989

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate23$203,230
AustedoDeutetrabenazine46$187,965
VraylarCariprazine Hcl55$79,506
Lurasidone Hcl213$36,339
Quetiapine Fumarate1,149$19,199
Aripiprazole302$16,449
RexultiBrexpiprazole11$15,795
Duloxetine Hcl784$14,281
Adderall XrDextroamphetamine/Amphetamine24$14,100
Venlafaxine Hcl ErVenlafaxine Hcl1,000$13,363
Trazodone Hcl978$13,116
Bupropion XlBupropion Hcl486$12,278
Mirtazapine791$11,475
Clonazepam1,242$10,382
Quetiapine Fumarate ErQuetiapine Fumarate164$8,360

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$108$203,23023 claims
AbbVieVraylar$842$79,50655 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,284 psychiatric/mental health providers in Massachusetts.

Other psychiatric/mental health in West Springfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →